Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | QPCT | Q16769 | 8/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | QPCTL | Q9NXS2 | 1/20 | 0.39 |
| ▸ | DRD2 | P14416 | 3/20 | 0.39 |
| ▸ | ROCK2 | O75116 | 2/20 | 0.39 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25425681 | 1.00 | QPCT (0.56) | QPCTALDH1A1TSHRSMN1; SMN2NPSR1 | |
| SCHEMBL29194470 | 0.95 | QPCT (0.59) | QPCTALDH1A1TSHRSMN1; SMN2NPSR1 | |
| SCHEMBL30245386 | 0.95 | QPCT (0.59) | QPCTALDH1A1TSHRSMN1; SMN2NPSR1 | |
| SCHEMBL30245366 | 0.91 | QPCT (0.59) | QPCTALDH1A1TSHRSMN1; SMN2NPSR1 | |
| SCHEMBL25425366 | 0.91 | QPCT (0.59) | QPCTALDH1A1TSHRSMN1; SMN2NPSR1 | |
| SCHEMBL25424733 | 0.91 | QPCT (0.55) | QPCTALDH1A1TSHRSMN1; SMN2NPSR1 | |
| SCHEMBL30244832 | 0.91 | QPCT (0.55) | QPCTALDH1A1TSHRSMN1; SMN2NPSR1 | |
| SCHEMBL30245014 | 0.90 | ALDH1A1 (0.48) | QPCTALDH1A1TSHRSMN1; SMN2NPSR1 | |
| SCHEMBL25427668 | 0.89 | QPCT (0.59) | QPCTALDH1A1TSHRSMN1; SMN2NPSR1 | |
| SCHEMBL30245461 | 0.89 | QPCT (0.59) | QPCTALDH1A1TSHRSMN1; SMN2NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4384516-A1 | AMINOARYL-INTEGRIN AGONISTS COMPOUNDS | Texas Heart Institute (US) | 2024-06-19 | — | — | EP | claimed |
| WO-2023018472-A9 | AMINOARYL-INTEGRIN AGONISTS COMPOUNDS | TEXAS HEART INSTITUTE (US) | 2023-07-13 | — | — | WO | claimed |
| WO-2023018472-A1 | AMINOARYL-INTEGRIN AGONISTS COMPOUNDS | TEXAS HEART INSTITUTE (US) | 2023-02-16 | — | — | WO | claimed |
| EP-4384516-A1 | AMINOARYL-INTEGRIN AGONISTS COMPOUNDS | Texas Heart Institute (US) | 2024-06-19 | — | — | EP | disclosed |
| WO-2023018472-A9 | AMINOARYL-INTEGRIN AGONISTS COMPOUNDS | TEXAS HEART INSTITUTE (US) | 2023-07-13 | — | — | WO | disclosed |
| WO-2023018472-A1 | AMINOARYL-INTEGRIN AGONISTS COMPOUNDS | TEXAS HEART INSTITUTE (US) | 2023-02-16 | — | — | WO | disclosed |